The unequal scramble for coronavirus vaccines - by the numbers

Nature. 2020 Aug;584(7822):506-507. doi: 10.1038/d41586-020-02450-x.
No abstract available

Keywords: Business; Public health; SARS-CoV-2; Vaccines.

Publication types

  • News

MeSH terms

  • COVID-19 Vaccines
  • Clinical Trials, Phase III as Topic
  • Confidentiality
  • Coronavirus Infections / economics
  • Coronavirus Infections / prevention & control
  • Developed Countries / economics*
  • Developed Countries / statistics & numerical data*
  • Drug Approval
  • Drug Costs / ethics
  • Drug Industry / economics
  • Drug Industry / ethics
  • Global Health / ethics*
  • Global Health / statistics & numerical data
  • Healthcare Disparities / ethics*
  • Healthcare Disparities / statistics & numerical data*
  • Hoarding / economics
  • Humans
  • Influenza A Virus, H1N1 Subtype / immunology
  • International Cooperation
  • Needs Assessment / ethics
  • Time Factors
  • Viral Vaccines / biosynthesis
  • Viral Vaccines / chemical synthesis
  • Viral Vaccines / economics*
  • Viral Vaccines / supply & distribution*

Substances

  • COVID-19 Vaccines
  • Viral Vaccines